Alina Zorn

Alina Zorn is PhD Student at the University of Glasgow, Scotland. Her research is primarily focused on developing protein-degrading drugs (PROTACS) for the treatment of cancer and neurodegenerative disease. 

Alina is a two-time graduate of the University of Aberdeen with a degree in Biomedical Sciences (Pharmacology & Biobusiness) and an MSci by Research in Medical Sciences. 



;function _(a){var r=t[a];if(void 0!==r)return r.exports;var n=t[a]={exports: